These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9239783)

  • 1. Protection from clinical varicella disease during interferon alpha-2a therapy for chronic active hepatitis B infection.
    Curtiss D; Kaufman S; Harrison CJ
    Pediatr Infect Dis J; 1997 Jul; 16(7):720-2. PubMed ID: 9239783
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of prednisone priming followed by alfa-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial.
    Utili R; Sagnelli E; Giusti G; Ruggiero G; Piccinino F; Galanti B; Adinolfi LE; Aprea L; Cesaro G; Digilio L
    Arch Virol Suppl; 1992; 4():277-80. PubMed ID: 1450701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance of chronic hepatitis B virus infection in young children after alpha interferon treatment.
    Narkewicz MR; Smith D; Silverman A; Vierling J; Sokol RJ
    J Pediatr; 1995 Nov; 127(5):815-8. PubMed ID: 7472844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B.
    Cianciara J; Laskus T
    Dig Dis Sci; 1995 Aug; 40(8):1842-4. PubMed ID: 7648989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant alpha interferon on chronic active hepatitis B: preliminary results.
    Bayraktar Y; Uzunalimoglu B; Arslan S; Koseoglu T; Kayhan B; Telatar H
    Gut; 1993; 34(2 Suppl):S101. PubMed ID: 8314468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of three doses of interferon-alpha 2a in chronic active hepatitis B. The International Hepatitis Trial Group.
    Thomas HC; Lok AS; Carreño V; Farrell G; Tanno H; Perez V; Dusheiko GM; Cooksley G; Ryff JC
    J Viral Hepat; 1994; 1(2):139-48. PubMed ID: 8790569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferon therapy in chronic viral hepatitis].
    Welland O
    Nord Med; 1992; 107(3):72-3, 75. PubMed ID: 1549455
    [No Abstract]   [Full Text] [Related]  

  • 8. Transient hypothyroidism in a child treated with alpha-interferon for chronic hepatitis B infection.
    Abdul-Jabbar MA; Ehrlich RM; Mann N; Roberts EA
    Clin Pediatr (Phila); 1995 Dec; 34(12):663-5. PubMed ID: 8665748
    [No Abstract]   [Full Text] [Related]  

  • 9. Zidovudine plus interferon alfa-2b treatment in patients with HIV and chronic active viral hepatitis.
    Visco G; Alba L; Grisetti S; Guarascio P; Narciso P; Sette P; Struglia C; Tossini G; Tozzi V
    Gut; 1993; 34(2 Suppl):S107-8. PubMed ID: 8314472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic viral hepatitis--benefits of current therapies.
    Hoofnagle JH; Lau D
    N Engl J Med; 1996 May; 334(22):1470-1. PubMed ID: 8618588
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon-alpha 2a increases serum concentration of hyaluronic acid and type III procollagen aminoterminal propeptide in patients with chronic hepatitis B virus infection.
    Zöhrens G; Armbrust T; Meyer Zum Büschenfelde KH; Ramadori G
    Dig Dis Sci; 1994 Sep; 39(9):2007-13. PubMed ID: 8082511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic anemia secondary to interferon treatment for chronic B hepatitis.
    Fornaciari G; Bassi C; Beltrami M; Castagnetti E; Maccari S; Plancher AC
    J Clin Gastroenterol; 1991 Oct; 13(5):596-7. PubMed ID: 1744407
    [No Abstract]   [Full Text] [Related]  

  • 13. Why we should treat chronic viral hepatitis.
    King PD
    Postgrad Med; 1996 Sep; 100(3):68-70, 73; discussion 73, 78. PubMed ID: 8795647
    [No Abstract]   [Full Text] [Related]  

  • 14. Alpha-interferon treatment of chronic hepatitis B infection: predictors of responsiveness.
    Dusheiko GM
    J Gastroenterol Hepatol; 1991; 6 Suppl 1():7-12. PubMed ID: 1751802
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term versus short-term treatment with recombinant interferon alfa-2a in patients with chronic hepatitis B: a prospective, randomized treatment trial.
    Rakela J; Wood JR; Czaja AJ; O'Brien PC; Taswell HF; Bowyer BA; Lange SM; Anderson ML; Parent K
    Mayo Clin Proc; 1990 Oct; 65(10):1330-5. PubMed ID: 2214880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of chronic hepatitis B with interferon alfa-2b (Intron A)].
    Cianciara J; Laskus T; Hryniewicz H; Jabłońska J; Loch T
    Przegl Epidemiol; 1991; 45(4):315-20. PubMed ID: 1841409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interferon induced IBD-like acute colitis--two cases of patients with chronic active hepatitis].
    Yamamoto Y; Sakatani N; Yano S; Kou K; Ochi S; Yoshida Y; Fujimoto R; Ohno K; Sawai S
    Nihon Shokakibyo Gakkai Zasshi; 1995 Sep; 92(9):1293-6. PubMed ID: 7474487
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of chronic hepatitis B, C and D with alpha-interferon].
    Niederau C
    Fortschr Med; 1993 Feb; 111(6):35-7. PubMed ID: 8462911
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical course of inflammatory bowel disease during treatment with interferon for associated chronic active hepatitis.
    Cottone M; Magliocco A; Trallori G; Brignola C; Vandelli C; Ardizzone S; Meucci G; Zannoni F; Di Maio G; Astegiano M
    Ital J Gastroenterol; 1995; 27(1):3-4. PubMed ID: 7795286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PreS1 antigen/antibody patterns following interferon therapy in acute and chronic hepatitis B.
    Petit MA; Zoulim F; Berthillon P; Capel F; Li J; Dauguet C; Ferrari C; Trépo C
    J Hepatol; 1994 Jan; 20(1):47-56. PubMed ID: 8201222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.